Fig. 4: Symptoms, age and gender distribution of participants with neutralising antibodies. | Communications Medicine

Fig. 4: Symptoms, age and gender distribution of participants with neutralising antibodies.

From: Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults

Fig. 4

Individual symptoms (a), correlation of the the number of symptoms with the neutralisation test (NT 1:X) result (b), distribution with regard to age group (c) and gender (d) among participants with neutralising antibodies evaluated in sera from the initial blood draw (day 0; n = 41). Neutralisation test (NT).

Back to article page